69 results on '"Sahin, Ugur"'
Search Results
2. Author Correction: Identification of neoantigens for individualized therapeutic cancer vaccines
3. Image compression with learned lifting-based DWT and learned tree-based entropy models
4. Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer
5. Immunological effects and activity of multiple doses of zolbetuximab in combination with zoledronic acid and interleukin-2 in a phase 1 study in patients with advanced gastric and gastroesophageal junction cancer
6. BNT162b2-elicited neutralization of Delta plus, Lambda, Mu, B.1.1.519, and Theta SARS-CoV-2 variants
7. Accurate detection of tumor-specific gene fusions reveals strongly immunogenic personal neo-antigens
8. IL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccines
9. Identification of neoantigens for individualized therapeutic cancer vaccines
10. Local radiotherapy and E7 RNA-LPX vaccination show enhanced therapeutic efficacy in preclinical models of HPV16+ cancer
11. BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants
12. BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans
13. mRNA therapeutics in cancer immunotherapy
14. Patient-reported outcomes from the phase II FAST trial of zolbetuximab plus EOX compared to EOX alone as first-line treatment of patients with metastatic CLDN18.2+ gastroesophageal adenocarcinoma
15. Iodine-124 PET quantification of organ-specific delivery and expression of NIS-encoding RNA
16. BNT162b vaccines protect rhesus macaques from SARS-CoV-2
17. Publisher Correction: COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses
18. COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses
19. Melphalan pharmacokinetics and transplant related toxicity during autologous stem cell transplantation
20. An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma
21. Blastic Plasmacytoid Dendritic Cell Neoplasm: Single Center Experience on a Rare Hematological Malignancy
22. OXPHOS remodeling in high-grade prostate cancer involves mtDNA mutations and increased succinate oxidation
23. Targeting the tumor vasculature with engineered cystine-knot miniproteins
24. Impact of molecular subtypes on the prediction of distant recurrence in estrogen receptor (ER) positive, human epidermal growth factor receptor 2 (HER2) negative breast cancer upon five years of endocrine therapy
25. Publisher Correction: Actively personalized vaccination trial for newly diagnosed glioblastoma
26. Actively personalized vaccination trial for newly diagnosed glioblastoma
27. Induction of immunosuppressive functions and NF-κB by FLIP in monocytes
28. Robustness of biomarker determination in breast cancer by RT-qPCR: impact of tumor cell content, DCIS and non-neoplastic breast tissue
29. An RNA toolbox for cancer immunotherapy
30. In vivo imaging of the immune response upon systemic RNA cancer vaccination by FDG-PET
31. Challenges towards the realization of individualized cancer vaccines
32. Enhanced stability of a chimeric hepatitis B core antigen virus-like-particle (HBcAg-VLP) by a C-terminal linker-hexahistidine-peptide
33. HLA and proteasome expression body map
34. Donor-recipient killer immunoglobulin like receptor (KIR) genotype matching has a protective effect on chronic graft versus host disease and relapse incidence following HLA-identical sibling hematopoietic stem cell transplantation
35. Prognostic impact of CD4-positive T cell subsets in early breast cancer: a study based on the FinHer trial patient population
36. Antigen-specific oncolytic MV-based tumor vaccines through presentation of selected tumor-associated antigens on infected cells or virus-like particles
37. Erratum: Elimination of large tumors in mice by mRNA-encoded bispecific antibodies
38. Trace elements in blood samples of smoker and nonsmoker active pulmonary tuberculosis patients from Jamshoro, Pakistan
39. Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
40. Elimination of large tumors in mice by mRNA-encoded bispecific antibodies
41. An international reproducibility study validating quantitative determination of ERBB2, ESR1, PGR, and MKI67 mRNA in breast cancer using MammaTyper®
42. Correction: Corrigendum: NFATc1 supports imiquimod-induced skin inflammation by suppressing IL-10 synthesis in B cells
43. Uptake of synthetic naked RNA by skin-resident dendritic cells via macropinocytosis allows antigen expression and induction of T-cell responses in mice
44. Technical validation of an RT-qPCR in vitro diagnostic test system for the determination of breast cancer molecular subtypes by quantification of ERBB2, ESR1, PGR and MKI67 mRNA levels from formalin-fixed paraffin-embedded breast tumor specimens
45. Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy
46. NFATc1 supports imiquimod-induced skin inflammation by suppressing IL-10 synthesis in B cells
47. Biological subtyping of early breast cancer: a study comparing RT-qPCR with immunohistochemistry
48. TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression
49. Erratum: Mutant MHC class II epitopes drive therapeutic immune responses to cancer
50. Mutant MHC class II epitopes drive therapeutic immune responses to cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.